Correlation Between Hexatronic Group and Chordate Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hexatronic Group and Chordate Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hexatronic Group and Chordate Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hexatronic Group AB and Chordate Medical Holding, you can compare the effects of market volatilities on Hexatronic Group and Chordate Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hexatronic Group with a short position of Chordate Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hexatronic Group and Chordate Medical.

Diversification Opportunities for Hexatronic Group and Chordate Medical

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hexatronic and Chordate is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Hexatronic Group AB and Chordate Medical Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chordate Medical Holding and Hexatronic Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hexatronic Group AB are associated (or correlated) with Chordate Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chordate Medical Holding has no effect on the direction of Hexatronic Group i.e., Hexatronic Group and Chordate Medical go up and down completely randomly.

Pair Corralation between Hexatronic Group and Chordate Medical

Assuming the 90 days trading horizon Hexatronic Group AB is expected to generate 0.66 times more return on investment than Chordate Medical. However, Hexatronic Group AB is 1.51 times less risky than Chordate Medical. It trades about 0.03 of its potential returns per unit of risk. Chordate Medical Holding is currently generating about -0.05 per unit of risk. If you would invest  3,355  in Hexatronic Group AB on September 24, 2024 and sell it today you would earn a total of  184.00  from holding Hexatronic Group AB or generate 5.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hexatronic Group AB  vs.  Chordate Medical Holding

 Performance 
       Timeline  
Hexatronic Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hexatronic Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Chordate Medical Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chordate Medical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Hexatronic Group and Chordate Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hexatronic Group and Chordate Medical

The main advantage of trading using opposite Hexatronic Group and Chordate Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hexatronic Group position performs unexpectedly, Chordate Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chordate Medical will offset losses from the drop in Chordate Medical's long position.
The idea behind Hexatronic Group AB and Chordate Medical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance